beta
BIVV
Bioverativ Inc.
Chart
Stats
Earnings
News
Splits
Dividends
Earnings
| Actual EPS |
|---|
| Consensus EPS |
| Estimated EPS |
| Number of Estimates |
| EPS Surprise |
Stats
Summary
Bioverativ Inc is a global biotechnology company which focuses on the discovery, research, development, and commercialization of innovative therapies for the treatment of hemophilia and other blood disorders.
Market Cap: 11.2 Billion
Primary Exchange: Nasdaq Global Select
Website: http://www.bioverativ.com
Shares Outstanding: 108 Million
Float: 108 Million
Dividend: 0.0 (0.0%)
Beta: 11.681932
Sector: Healthcare
Industry: Biotechnology
Ethical Flags
Longest drawdown: 118 trading days
From: 2017-07-25 To: 2018-01-11
Lowest Point:
| Ex-Date | Payment Date | Record Date | Declared Date | Amount | Flag | Dividend Type | Qualified | Indicated |
|---|
| Ex-Date | Declared Date | Record Date | Payment Date | Ratio | To Factor | For Factor |
|---|